Neurotransmitter Regulation of Basal Ganglia Gene Expression

Handbook of Behavioral Neuroscience

Volumn 20, Issue C, 2010, Pages 461-490

  Keefe, Kristen A ^a   Horner, Kristen A ^b  

^a UNIVERSITY OF UTAH   (United States)

^b MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955159293     PISSN: 15697339     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-374767-9.00027-5     Document Type: Chapter

References (308)

1. Abercrombie, ED, Bonatz, AE, Zigmond, MJ, Effects of 1-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res 525 (1990), 36–44.
2. Adams, AC, Keefe, KA, Degree of immediate early gene induction in striatum by eticlopride determines sensitivity to N-methyl-D-aspartate receptor blockade. Brain Res 885 (2000), 201–207.
3. Adams, AC, Layer, RT, McCabe, RT, Keefe, KA, Effects of conantokins on L-3,4-dihydroxyphenylalanine-induced behavior and immediate early gene expression. Eur J Pharmacol 404 (2000), 303–313.
4. Alonso, R, Gnanadicom, H, Fréchin, N, Fournier, M, Le Fur, G, Soubrié, P, Blockade of neurotensin receptors suppresses the dopamine D1/D2 synergism on immediate early gene expression in the rat brain. Eur J Neurosci 11 (1999), 967–974.
5. Alvaro, JD, Tatro, JB, Quillan, JM, Fogliano, M, Eisenhard, M, Lerner, MR, Nestler, EJ, Duman, RS, Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction. Mol Pharmacol 50 (1996), 583–591.
6. Ammon, S, Mayer, P, Riechert, U, Tischmeyer, H, Hollt, V, Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone-precipitated withdrawal. Brain Res Mol Brain Res 112 (2003), 113–125.
7. Angulo, JA, Davis, LG, Burkhart, BA, Christoph, GR, Reduction of striatal dopaminergic neurotransmission elevates striatal proenkephalin mRNA. Eur J Pharmacol 130 (1986), 341–343.
8. Angulo, JA, Watanabe, Y, Cadet, J, Ledoux, M, McEwen, BS, Upregulation of forebrain proenkephalin mRNA subsequent to NMDA receptor blockade. Eur J Pharmacol 244 (1993), 317–318.
9. Angulo, JA, Williams, A, Ledoux, M, Watanabe, Y, McEwen, BS, Elevation of striatal and accumbal preproenkephalin, preprotachykinin and preprodynorphin mRNA abundance subsequent to N-methyl-D-aspartate receptor blockade with MK-801. Brain Res Mol Brain Res 29 (1995), 15–22.
10. Aoyama, S, Kase, H, Borrelli, E, Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist. J Neurosci 20 (2000), 5848–5852.
11. Arden, J, Segredo, W, Wang, Z, Lameh, J, Sadee, W, Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK293 cells. J Neurochem 65 (1995), 1636–1645.
12. Aubert, I, Ghorayeb, I, Normand, E, Bloch, B, Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum. J Comp Neurol 418 (2000), 22–32.
13. Augood, SJ, Westmore, K, Emson, PC, Phenotypic characterization of neurotensin messenger RNA-expressing cells in the neuroleptic-treated rat striatum: a detailed cellular co-expression study. Neuroscience 76 (1997), 763–774.
14. Azzi, M, Boudin, H, Mahmudi, N, Pelaprat, D, Rostene, W, Berod, A, In vivo regulation of neurotensin receptors following long-term pharmacological blockade with a specific receptor antagonist. Brain Res Mol Brain Res 42 (1996), 221–231.
15. Basheer, R, Tempel, A, Morphine-induced reciprocal alterations in G alpha s and opioid peptide mRNA levels in discrete brain regions. J Neurosci Res 36 (1993), 551–557.
16. Beaudry, G, Langlois, M-C, Weppe, I, Rouillard, C, Levesque, D, Contrasting patterns and cellular specificity of transcriptional regulation of the nuclear receptor nerve growth factor-inducible B by haloperidol and clozapine in the rat forebrain. J Neurochem 75 (2000), 1694–1702.
17. Beckstead, RM, The thalamostriatal projection in the cat. J Comp Neurol 223 (1984), 313–346.
18. Beckstead, RM, N-methyl-D-aspartate acutely increases proenkephalin mRNA in the rat striatum. Synapse 21 (1995), 342–347.
19. Bennett, HJ, Semba, K, Immunohistochemical localization of caffeine-induced c-Fos protein expression in the rat brain. J Comp Neurol 401 (1998), 89–108.
20. Berendse, HW, Groenewegen, HJ, Organization of the thalamostriatal projections in the rat, with special emphasis on the ventral striatum. J Comp Neurol 299 (1990), 187–228.
21. Bergstrom, BP, Garris, PA, “Passive stabilization” of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6-OHDA-lesioned rat. J Neurochem 87 (2003), 1224–1236.
22. Berke, JD, Paletzki, RF, Aronson, GJ, Hyman, SE, Gerfen, CR, A complex program of striatal gene expression induced by dopaminergic stimulation. J Neurosci 18 (1998), 5301–5310.
23. Berke, JD, Sgambato, V, Zhu, PP, Lavoie, B, Vincent, M, Krause, M, Hyman, SE, Dopamine and glutamate induce distinct striatal splice forms of Ania-6, an RNA polymerase II-associated cyclin. Neuron 32 (2001), 277–287.
24. Bernard, V, Dumartin, B, Lamy, E, Bloch, B, Fos immunoreactivity after stimulation or inhibition of muscarinic receptors indicates anatomical specificity for cholinergic control of striatal efferent neurons and cortical neurons in the rat. Eur J Neurosci 5 (1993), 1218–1225.
25. Berretta, S, Parthasarathy, HB, Graybiel, AM, Local release of GABAergic inhibition in the motor cortex induces immediate-early gene expression in indirect pathway neurons of the striatum. J Neurosci 17 (1997), 4752–4763.
26. Berretta, S, Robertson, HA, Graybiel, AM, Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. J Neurophysiol 68 (1992), 767–777.
27. Berretta, S, Robertson, HA, Graybiel, AM, Neurochemically specialized projection neurons of the striatum respond differentially to psychomotor stimulants. Prog Brain Res 99 (1993), 201–205.
28. Bertran-Gonzalez, J, Bosch, C, Maroteaux, M, Matamales, M, Hervé, D, Valjent, E, Girault, JA, Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J Neurosci 28 (2008), 5671–5685.
29. Bilecki, W, Wawrzczak-Bargiela, A, Przewlocki, R, Activation of AP-1 and CRE-dependent gene expression via mu-opioid receptor. J Neurochem 90 (2004), 874–882.
30. Billings, LM, Marshall, JF, D2 antagonist-induced c-fos in an identified subpopulation of globus pallidus neurons by a direct intrapallidal action. Brain Res 964 (2003), 237–243.
31. Billings, LM, Marshall, JF, Glutamic acid decarboxylase 67 mRNA regulation in two globus pallidus neuron populations by dopamine and the subthalamic nucleus. J Neurosci 24 (2004), 3094–3103.
32. Binder, EB, Kinkead, B, Owens, MJ, Nemerof, CB, Neurotensin receptor antagonist SR 142948A alters Fos expression and extrapyramidal side effect profile of typical and atypical antipsychotic drugs. Neuropsychopharmacology 29 (2004), 2200–2207.
33. Boegman, RJ, Vincent, SR, Involvement of adenosine and glutamate receptors in the induction of c-fos in the striatum by haloperidol. Synapse 22 (1996), 70–77.
34. Bourson, A, Boess, FG, Bos, N, Sleight, AJ, Involvement of 5-HT6 receptors in nigro-striatal function in rodents. Br J Pharmacol 125 (1998), 1562–1566.
35. Burford, N, Tobler, L, Sadee, W, Specific G protein activation and μ-opioid receptor internalization caused by morphine, DAMGO and endomorphin-1. Eur J Pharmcol 342 (1998), 123–126.
36. Campbell, BM, Kreipke, CW, Walker, PD, Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat. Neuroscience 137 (2006), 505–517.
37. Capper-Loup, C, Canales, JJ, Kadaba, N, Graybiel, AM, Concurrent activation of dopamine D1 and D2 receptors is required to evoke neural and behavioral phenotypes of cocaine sensitization. J Neurosci 22 (2002), 6218–6227.
38. Castañeda, E, Whishaw, IQ, Robinson, TE, Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size. J Neurosci 10 (1990), 1847–1854.
39. Castelli, MP, Melis, M, Mameli, M, Fadda, P, Diaz, G, Gessa, GL, Chronic morphine and naltrexone fail to modify mu-opioid receptor mRNA levles in the rat brain. Brain Res Mol Brain Res 45 (1997), 149–153.
40. Castro, E, Tordera, RM, Hughes, ZA, Pei, Q, Sharp, T, Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist co-administration. J Neurochem 85 (2003), 1480–1487.
41. Cenci, MA, Campbell, K, Bjorklund, A, Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels. Neuroscience 57 (1993), 275–296.
42. Cenci, MA, Campbell, K, Wictorin, K, Björklund, A, Striatal c-fos induction by cocaine or apomorphine occurs preferentially in output neurons projecting to the substantia nigra in the rat. Eur J Neurosci 4 (1992), 376–380.
43. Chapman, DE, Hanson, GR, Kesner, RP, Keefe, KA, Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine. J Pharmacol Exp Ther 296 (2001), 520–527.
44. Chartoff, EH, Ward, RP, Dorsa, DM, Role of adenosine and N-methyl-D-aspartate receptors in mediating haloperidol-induced gene expression and catalepsy. J Pharmacol Exp Ther 291 (1999), 531–537.
45. Chen, JF, Moratalla, R, Impagnatiello, F, et al. The role of the D(2) dopamine receptor [D(2)R] in A(2A) adenosine receptor [A(2A)R]-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice. Proc Natl Acad Sci USA 98 (2001), 1970–1975.
46. Chergui, K, Svenningsson, P, Nomikos, GG, Gonon, F, Fredholm, BB, Svennson, TH, Increased expression of NGFI-A mRNA in the rat striatum following burst stimulation of the medial forebrain bundle. Eur J Neurosci 9 (1997), 2370–2382.
47. Chou, H, Ogawa, N, Asanuma, M, Hirata, H, Mori, A, Muscarinic cholinergic receptor-mediated modulation on striatal c-fos mRNA expression induced by levodopa in rat brain. J Neural Transm Gen Sect 90 (1992), 171–181.
48. Cole, DG, Di Figlia, M, Reserpine increases Fos activity in the rat basal ganglia via a quinpirole-sensitive mechanism. Neuroscience 60 (1994), 115–123.
49. Cole, RL, Konradi, C, Douglass, J, Hyman, SE, Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 14 (1995), 813–823.
50. Collins, S, D'Addario, C, Romualdi, P, Candeletti, S, Izenwasser, S, Regulation of dynorphin gene expression by kappa-opioid agonist treatment. Neuroreport 13 (2002), 107–109.
51. Curran, EJ, Akil, H, Watson, SJ, Psychomotor stimulant- and opiate-induced c-fos mRNA expression patterns in the rat forebrain: comparisons between acute drug treatment and a drug challenge in sensitized animals. Neurochem Res 21 (1996), 1425–1435.
52. Daberkow, DP, Riedy, MD, Kesner, RP, Keefe, KA, Effect of methamphetamine neurotoxicity on learning-induced Arc mRNA expression in identified striatal efferent neurons. Neurotox Res 14 (2008), 307–315.
53. Das, S, Grunert, M, Williams, L, Vincent, SR, NMDA and D1 receptors regulate the phosphorylation of CREB and the induction of c-fos in striatal neurons in primary culture. Synapse 25 (1997), 227–233.
54. Dassesse, D, Ledent, C, Parmentier, M, Schiffmann, SN, Acute and chronic caffeine administration differentially alters striatal gene expression in wild-type and adenosine A(2A) receptor-deficient mice. Synapse 42 (2001), 63–76.
55. Dassesse, D, Massie, A, Ferrari, R, Ledent, C, Parmentier, M, Arckens, L, Zoli, M, Schiffmann, SN, Functional striatal hypodopaminergic activity in mice lacking adenosine A(2A) receptors. J Neurochem 78 (2001), 183–198.
56. Dassesse, D, Vanderwinden, JM, Goldberg, I, Vanderhaeghen, JJ, Schiffmann, SN, Caffeine-mediated induction of c-fos, zif-268 and arc expression through A1 receptors in the striatum: different interactions with the dopaminergic system. Eur J Neurosci 11 (1999), 3101–3114.
57. de Bartolomeis, A, Aloj, L, Ambesi-Impiombato, A, Bravi, D, Caracò, C, Muscettola, G, Barone, P, Acute administration of antipsychotics modulates Homer striatal gene expression differentially. Brain Res Mol Brain Res 98 (2002), 124–129.
58. de Souza, IE, Meredith, GE, NMDA receptor blockade attenuates the haloperidol induction of Fos protein in the dorsal but not the ventral striatum. Synapse 32 (1999), 243–253.
59. Decker, KP, Roy-Byrne, PP, Merchant, KM, Effect of muscimol on haloperidol-induced alteration of neurotensin gene expression in the striatum and nucleus accumbens in the rat. Brain Res 691 (1995), 9–17.
60. Delfs, JM, Ciaramitaro, VM, Parry, TJ, Chesselet, MF, Subthalamic nucleus lesions: widespread effects on changes in gene expression induced by nigrostriatal dopamine depletion in rats. J Neurosci 15 (1995), 6562–6575.
61. Dhatt, RK, Gudehithlu, KP, Wemlinger, TA, Tejwani, GA, Neff, NH, Hadjiconstantinou, M, Preproenkephalin mRNA and methionine-enkephalin content are increased in mouse striatum after treatment with nicotine. J Neurochem 64 (1995), 1878–1883.
62. Diaz Heijtz, R, Castellanos, FX, Differential effects of a selective dopamine D1-like receptor agonist on motor activity and c-fos expression in the frontal-striatal circuitry of SHR and Wistar-Kyoto rats. Behav Brain Func, 2, 2006, 18.
63. Ding, XZ, Mocchetti, I, Regulation of cholecystokinin mRNA content in rat striatum: a glutamatergic hypothesis. J Pharmacol Exp Ther 263 (1992), 368–373.
64. Dragunow, M, Logan, B, Laverty, R, 3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat basal ganglia: reversal with MK 801. Eur J Pharmacol 206 (1991), 255–258.
65. Dragunow, M, Robertson, GS, Faull, RL, Robertson, HA, Jansen, K, D2 dopamine receptor antagonists induce Fos and related proteins in rat striatal neurons. Neuroscience 37 (1990), 287–294.
66. Dunah, AW, Standaert, DG, Subcellular segregation of distinct heteromeric NMDA glutamate receptors in the striatum. J Neurochem 85 (2003), 935–943.
67. Engber, TM, Susel, Z, Kuo, S, Gerfen, CR, Chase, TN, Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats. Brain Res 552 (1991), 113–118.
68. Erdtmann-Vourliotis, M, Mayer, P, Riechert, U, Crecksch, G, Hollt, V, Identification of brain regions that are markedly activated by morphine in tolerant but not naive rats. Brain Res Mol Brain Res 61 (1998), 51–61.
69. Ethier, I, Beaudry, G, St-Hilaire, M, Milbrandt, J, Rouillard, C, Lévesque, D, The transcription factor NGFI-B (Nur77) and retinoids play a critical role in acute neuroleptic-induced extrapyramidal effect and striatal neuropeptide gene expression. Neuropsychopharmacology 29 (2004), 335–346.
70. Fadel, J, Dobner, PR, Deutch, AY, The neurotensin antagonist SR 49892 attenuates haloperidol-induced striatal Fos expression in the rat. Neurosci Lett 303 (2001), 17–20.
71. Fadel, J, Dobner, PR, Deutch, AY, Amphetamine-elicited striatal Fos expression is attenuated in neurotensin null mutant mice. Neurosci Lett 402 (2006), 97–101.
72. Fenu, S, Pinna, A, Ongini, E, Morelli, M, Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats. Eur J Pharmacol 321 (1997), 143–147.
73. Ferguson, SM, Norton, CS, Watson, SJ, Akil, H, Robinson, TE, Amphetamine-evoked c-fos mRNA expression in the caudate-putamen: the effects of DA and NMDA receptor antagonists vary as a function of neuronal phenotype and environmental context. J Neurochem 86 (2003), 33–44.
74. Ferguson, SM, Robinson, TE, Amphetamine-evoked gene expression in striatopallidal neurons: regulation by corticostriatal afferents and the ERK/MAPK signaling cascade. J Neurochem 91 (2004), 337–348.
75. Ferrari, R, Le Novère, N, Picciotto, MR, Changeux, JP, Zoli, M, Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections. Eur J Neurosci 15 (2002), 1810–1818.
76. Ferre, S, O'Connor, WT, Svenningsson, P, et al. Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms. Eur J Neurosci 8 (1996), 1545–1553.
77. Ferré, S, Karcz-Kubicha, M, Hope, BT, et al. Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: Implications for striatal neuronal function. Proc Natl Acad Sci USA 99 (2002), 11940–11945.
78. Ferré, S, Quiroz, C, Woods, AS, Cunha, R, Popoli, P, Ciruela, F, Lluis, C, Franco, R, Azdad, K, Schiffmann, SN, An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors. Curr Pharm Des 14 (2008), 1468–1474.
79. Ferré, S, Rimondini, R, Popoli, P, Reggio, R, Pèzzola, A, Hansson, AC, Andersson, A, Fuxe, K, Stimulation of adenosine A1 receptors attenuates dopamine D1 receptor-mediated increase of NGFI-A, c-fos and jun-B mRNA levels in the dopamine-denervated striatum and dopamine D1 receptor-mediated turning behaviour. Eur J Neurosci 11 (1999), 3884–3892.
80. Fibiger, HC, Neuroanatomical targets of neuroleptic drugs as revealed by Fos immunochemistry. J Clin Psychiatry 55:Suppl B (1994), 33–36.
81. Fink, JS, Weaver, DR, Rivkees, SA, Peterfreund, RA, Pollack, AE, Adler, EM, Reppert, SM, Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. Brain Res Mol Brain Res 14 (1992), 186–195.
82. Fu, L, Beckstead, RM, Cortical stimulation induces fos expression in striatal neurons. Neuroscience 46 (1992), 329–334.
83. Fumagalli, F, Frasca, A, Racagni, G, Riva, MA, Antipsychotic drugs modulate Arc expression in the rat brain. Eur Neuropsychopharmacol 19 (2009), 109–115.
84. Ganguly, A, Keefe, KA, Effects of MK-801 on D1 dopamine receptor-mediated immediate early gene expression in the dopamine-depleted striatum. Brain Res 871 (2000), 156–159.
85. Georges, F, Stinus, L, Bloch, B, Le Moine, C, Chronic morphine exposure and spontaneous withdrawal are assoicated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum. Eur J Neurosci 11 (1999), 481–490.
86. Georges, F, Stinus, L, Le Moine, C, Mapping of c-fos gene expresion in the brain during morphine dependence and precipitated withdrawal, and phenotypic identification of the striatal neurons involved. Eur J Neurosci 12 (2000), 4475–4486.
87. Gerfen, CR, Engber, TM, Mahan, LC, Susel, Z, Chase, TN, Monsma, FJ Jr., Sibley, DR, D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250 (1990), 1429–1432.
88. Gerfen, CR, Keefe, KA, Gauda, EB, D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J Neurosci 15 (1995), 8167–8176.
89. Gerfen, CR, Miyachi, S, Paletzki, R, Brown, P, D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase. J Neurosci 22 (2002), 5042–5054.
90. Gervais, J, Soghomonian, JJ, Richard, D, Rouillard, C, Dopamine and serotonin interactions in the modulation of the expression of the immediate-early transcription factor, nerve growth factor-inducible B, in the striatum. Neuroscience 91 (1999), 1045–1054.
91. Gonzalez-Nicolini, MV, Berglind, W, Cole, KS, Keogh, CL, McGinty, JF, Local mu and delta opioid receptors regulate amphetamine-induced behavior and neuropeptide mRNA in the striatum. Neuroscience 121 (2003), 387–398.
92. Gonzalez-Nicolini, V, McGinty, JF, NK-1 receptor blockade decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum. Brain Res 931 (2002), 41–49.
93. Gotoh, L, Kawanami, N, Nakahara, T, et al. Effects of the adenosine A(1) receptor agonist N(6)-cyclopentyladenosine on phencyclidine-induced behavior and expression of the immediate-early genes in the discrete brain regions of rats. Brain Res Mol Brain Res 100 (2002), 1–12.
94. Graybiel, AM, Acute effects of psychomotor stimulant drugs on gene expression in the striatum. NIDA Res Monogr 125 (1993), 72–81.
95. Gresch, PJ, Walker, PD, Acute p-chloroamphetamine increases striatal preprotachykinin mRNA: role of the serotonin 2A/2C receptor. Brain Res Mol Brain Res 67 (1999), 190–193.
96. Gresch, PJ, Walker, PD, Serotonin-2 receptor stimulation normalizes striatal preprotachykinin messenger RNA in an animal model of Parkinson's disease. Neuroscience 93 (1999), 831–841.
97. Gudehithlu, KP, Bhargava, HN, Modulation of preproenkphalin mRNA levels in brain regions and spinal cord of rats treated chronically with morphine. Peptides 16 (1995), 415–419.
98. Guerra, MJ, Liste, I, Labandeira-Garcia, JL, Interaction between the serotonergic, dopaminergic, and glutamatergic systems in fenfluramine-induced Fos expression in striatal neurons. Synapse 28 (1998), 71–82.
99. Guo, N, Robertson, GS, Fibiger, HC, Scopolamine attenuates haloperidol-induced c-fos expression in the striatum. Brain Res 588 (1992), 164–167.
100. Guzowski, J, Setlow, B, Wagner, E, McGaugh, J, Experience-dependent gene expression in the rat hippocampus after spatial learning: a comparison of the immediate-early genes Arc, c-fos, and zif268. J Neurosci 21 (2001), 5089–5098.
101. Halimi, G, Devaux, C, Clot-Faybesse, O, Sampol, J, Legof, L, Rochat, H, Guieu, R, Modulation of adenosine concentration by opioid receptor agonist in rat striatum. Eur J Pharmacol 398 (2000), 217–224.
102. Hansen, HH, Timmermann, DB, Peters, D, Walters, C, Damaj, MI, Mikkelsen, JD, Alpha-7 nicotinic acetylcholine receptor agonists selectively activate limbic regions of the rat forebrain: an effect similar to antipsychotics. J Neurosci Res 85 (2007), 1810–1818.
103. Hanson, G, Bush, L, Keefe, K, Alburges, M, Distinct responses of basal ganglia substance P systems to low and high doses of methamphetamine. J Neurochem 82 (2002), 1171–1178.
104. Hanson, GR, Keefe, KA, Dopamine D-1 regulation of caudate neurotensin mRNA in the presence or absence of the nigrostriatal dopamine pathway. Brain Res Mol Brain Res 66 (1999), 111–121.
105. Harrison, LM, Kastin, AJ, Zadina, JE, Tyr-W-MIF-1 attenuates down-regulation of opiate receptors in SH-SY5Y human neuroblastoma cells. J Pharmacol Exp Ther 284 (1998), 611–617.
106. Hatton, CJ, Paoletti, P, Modulation of triheteromeric NMDA receptors by N-terminal domain ligands. Neuron 46 (2005), 261–274.
107. Hayashi, T, Tsao, L, Cadet, JL, Su, TP, [D-Ala2, D-Leu5]enkephalin blocks the methamphetamine-induced c-fos mRNA increase in mouse striatum. Eur J Pharmacol 366 (1999), R7–R8.
108. Healy, DJ, Meador-Woodruff, JH, Ionotropic glutamate receptor modulation of 5-HT6 and 5-HT7 mRNA expression in rat brain. Neuropsychopharmacology 21 (1999), 341–351.
109. Hersch, SM, Ciliax, BJ, Gutekunst, CA, et al. Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J Neurosci 15 (1995), 5222–5237.
110. Hess, US, Whalen, SP, Sandoval, LM, Lynch, G, Gall, CM, Ampakines reduce methamphetamine-driven rotation and activate neocortex in a regionally selective fashion. Neuroscience 121 (2003), 509–521.
111. Hollen, KM, Nakabeppu, Y, Davies, SW, Changes in expression of delta FosB and the Fos family proteins following NMDA receptor activation in the rat striatum. Brain Res Mol Brain Res 47 (1997), 31–43.
112. Hoover, BR, Marshall, JF, Further characterization of preproenkephalin mRNA-containing cells in the rodent globus pallidus. Neuroscience 111 (2002), 111–125.
113. Horner, KA, Keefe, KA, Regulation of psychostimulant-induced preprodynorphin, c-fos and zif/268 messenger RNA expression in the rat dorsal striatum by mu opioid receptor blockade. Eur J Pharmacol 532 (2006), 61–73.
114. Houdi, AA, Dasgupta, R, Kindy, MS, Effect of nicotine use and with-drawal on brain preproenkephalin A mRNA. Brain Res 799 (1998), 257–263.
115. Humblot, N, Thiriet, N, Gobaille, S, Aunis, D, Zwiller, J, The serotonergic system modulates the cocaine-induced expression of the immediate early genes egr-1 and c-fos in rat brain. Ann NY Acad Sci 844 (1998), 7–20.
116. Humpel, C, Saria, A, Intranigral injection of selective neurokinin-1 and neurokinin-3 but not neurokinin-2 receptor agonists biphasically modulate striatal dopamine metabolism but not striatal preprotachykinin-A mRNA in the rat. Neurosci Lett 157 (1993), 223–226.
117. Hussain, N, Flumerfelt, BA, Rajakumar, N, Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens. Neuroscience 102 (2001), 391–399.
118. Hussain, N, Flumerfelt, BA, Rajakumar, N, Muscarinic, adenosine A(2) and histamine H(3) receptor modulation of haloperidol-induced c-fos expression in the striatum and nucleus accumbens. Neuroscience 112 (2002), 427–438.
119. Höllt, V, Horn, G, Effect of nicotine on mRNA levels encoding opioid peptides, vasopressin and alpha 3 nicotinic receptor subunit in the rat. The Clinical investigator 70 (1992), 224–231.
120. Ishikawa, K, Nitta, A, Mizoguchi, H, Mohri, A, Murai, R, Miyamoto, Y, Noda, Y, Kitaichi, K, Yamada, K, Nabeshima, T, Effects of single and repeated administration of methamphetamine or morphine on neuroglycan C gene expression in the rat brain. Int J Neuropsychopharmacology 9 (2006), 407–415.
121. Isola, R, Zhang, H, Tejwani, GA, Neff, NH, Hadjiconstantinou, M, Acute nicotine changes dynorphin and prodynorphin mRNA in the striatum. Psychopharmacology (Berl) 201 (2009), 507–516.
122. Jackson, DM, Westlind-Danielsson, A, Dopamine receptors: Molecular biology, biochemistry and behavioural aspects. Pharmacol Ther 64 (1994), 291–370.
123. Jian, M, Staines, WA, Iadarola, MJ, Robertson, GS, Destruction of the nigrostriatal pathway increases Fos-like immunoreactivity predominantly in striatopallidal neurons. Brain Res Mol Brain Res 19 (1993), 156–160.
124. Johnson-Davis, KL, Hanson, GR, Keefe, KA, Long-term post-synaptic consequences of methamphetamine on preprotachykinin mRNA expression. J Neurochem 82 (2002), 1472–1479.
125. Jolkkonen, J, Jenner, P, Marsden, CD, GABAergic modulation of striatal peptide expression in rats and the alterations induced by dopamine antagonist treatment. Neurosci Lett 180 (1994), 273–276.
126. Kaatz, KW, Albin, RL, Intrastriatal and intrasubthalamic stimulation of metabotropic glutamate receptors: a behavioral and Fos immunohistochemical study. Neuroscience 66 (1995), 55–65.
127. Karcz-Kubicha, M, Ferré, S, Díaz-Ruiz, O, Quiroz-Molina, C, Goldberg, SR, Hope, BT, Morales, M, Stimulation of adenosine receptors selectively activates gene expression in striatal enkephalinergic neurons. Neuropsychopharmacology 31 (2006), 2173–2179.
128. Karcz-Kubicha, M, Quarta, D, Hope, BT, et al. Enabling role of adenosine A1 receptors in adenosine A2A receptor-mediated striatal expression of c-fos. Eur J Neurosci 18 (2003), 296–302.
129. Kearney, JA, Frey, KA, Albin, RL, Metabotropic glutamate agonist-induced rotation: a pharmacological, Fos immunohistochemical, and [14C]-2-deoxyglucose autoradiographic study. J Neurosci 17 (1997), 4415–4425.
130. Keefe, KA, Adams, AC, Differential effects of N-methyl-D-aspartate receptor blockade on eticlopride-induced immediate early gene expression in the medial and lateral striatum. J Pharmacol Exp Ther 287 (1998), 1076–1083.
131. Keefe, KA, Ganguly, A, Effects of NMDA receptor antagonists on D1 dopamine receptor-mediated changes in striatal immediate early gene expression: Evidence for involvement of pharmacologically distinct NMDA receptors?. Dev Neurosci 20 (1998), 216–228.
132. Keefe, KA, Gerfen, CR, D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors. J Comp Neurol 367 (1996), 165–176.
133. Keefe, KA, Gerfen, CR, Local infusion of the (+/−)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione does not block D1 dopamine receptor-mediated increases in immediate early gene expression in the dopamine-depleted striatum. Neuroscience 89 (1999), 491–504.
134. Kemp, JM, Powell, TP, The cortico-striate projection in the monkey. Brain 93 (1970), 525–546.
135. Kiba, H, Jayaraman, A, Nicotine induced c-fos expression in the striatum is mediated mostly by dopamine D1 receptor and is dependent on NMDA stimulation. Brain Res Mol Brain Res 23 (1994), 1–13.
136. Kinsey, AM, Wainwright, A, Heavens, R, Sirinathsinghji, DJ, Oliver, KR, Distribution of 5-ht(5A), 5-ht(5B), 5-ht(6) and 5-HT(7) receptor mRNAs in the rat brain. Brain Res Mol Brain Res 88 (2001), 194–198.
137. Konieczny, J, Wardas, J, Kuter, K, Pilc, A, Ossowska, K, The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats. Neuroscience 145 (2007), 611–620.
138. Konradi, C, The molecular basis of dopamine and glutamate interactions in the striatum. Goldstein, DS, Eisenhofer, G, McCarty, R, (eds.) Advances in Pharmacology; Catecholamines: Bridging Basic Science with Clinical Medicine, 1998, Academic Press, San Diego, 729–733.
139. Konradi, C, Cole, RL, Heckers, S, Hyman, SE, Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J Neurosci 14 (1994), 5623–5634.
140. Konradi, C, Leveque, JC, Hyman, SE, Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J Neurosci 16 (1996), 4231–4239.
141. Kovoor, A, Celver, J, Wu, A, Chavin, C, Agonist-induced homologous desensitization of mu opioid receptors mediated by G protein-coupled kinases is dependent on agonist efficacy. Mol Pharm 54 (1998), 704–711.
142. LaHoste, GJ, Henry, BL, Marshall, JF, Dopamine D1 receptors synergize with D2, but not D3 or D4, receptors in the striatum without the involvement of action potentials. J Neurosci 20 (2000), 6666–6671.
143. LaHoste, GJ, Yu, J, Marshall, JF, Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. Proc Natl Acad Sci USA 90 (1993), 7451–7455.
144. Laprade, N, Soghomonian, JJ, MK-801 decreases striatal and cortical GAD65 mRNA levels. Neuroreport 6 (1995), 1885–1889.
145. Le Foll, B, Diaz, J, Sokoloff, P, Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats. Synapse 47 (2003), 176–183.
146. Le Moine, C, Bloch, B, D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J Comp Neurol 355 (1995), 418–426.
147. Le Moine, C, Normand, E, Guitteny, AF, Fouque, B, Teoule, R, Bloch, B, Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc Natl Acad Sci USA 87 (1990), 230–234.
148. Le Moine, C, Svenningsson, P, Fredholm, BB, Bloch, B, Dopamine-adenosine interactions in the striatum and the globus pallidus: Inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression. J Neurosci 17 (1997), 8038–8048.
149. Ledent, C, Vaugeois, JM, Schiffmann, SN, et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388 (1997), 674–678.
150. Lee, J, Rajakumar, N, Role of NR2B-containing N-methyl-D-aspartate receptors in haloperidol-induced c-Fos expression in the striatum and nucleus accumbens. Neuroscience 122 (2003), 739–745.
151. Linden, AM, Bergeron, M, Schoepp, DD, Comparison of c-Fos induction in the brain by the mGlu2/3 receptor antagonist LY341495 and agonist LY354740: evidence for widespread endogenous tone at brain mGlu2/3 receptors in vivo. Neuropharmacology 49:Suppl 1 (2005), 120–134.
152. Liste, I, Rozas, G, Guerra, MJ, Labandeira-Garcia, JL, Cortical stimulation induces Fos expression in striatal neurons via NMDA glutamate and dopamine receptors. Brain Res 700 (1995), 1–12.
153. Liu, J, Nickolenko, J, Sharp, FR, Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors. Proc Natl Acad Sci USA 91 (1994), 8537–8541.
154. Lucas, JJ, Segu, L, Hen, R, 5-Hydroxytryptamine1B receptors modulate the effect of cocaine on c-fos expression: converging evidence using 5-hydroxytryptamine1B knockout mice and the 5-hydroxytryptamine1B/1D antagonist GR127935. Mol Pharmacol 51 (1997), 755–763.
155. Lynch, G, Glutamate-based therapeutic approaches: ampakines. Curr Opin Pharmacol 6 (2006), 82–88.
156. MacGibbon, GA, Lawlor, PA, Hughes, P, Young, D, Dragunow, M, Differential expression of inducible transcription factors in basal ganglia neurons. Brain Res Mol Brain Res 34 (1995), 294–302.
157. Mackler, SA, Eberwine, JH, Cellular adaptation to opiates alters ion-channel mRNA levels. Proc Natl Acad Sci USA 91 (1994), 385–389.
158. Mahan, LC, McVittie, LD, Smyk-Randall, EM, Nakata, H, Monsma, FJ, Gerfen, CR, Sibley, DR, Cloning and expression of an A1 adenosine receptor from rat brain. Mol Pharmacol 40 (1991), 1–7.
159. Mannoury la Cour, C, Vidal, S, Pasteau, V, Cussac, D, Millan, MJ, Dopamine D1 receptor coupling to Gs/olf and Gq in rat striatum and cortex: a scintillation proximity assay (SPA)/antibody-capture characterization of benzazepine agonists. Neuropharmacology 52 (2007), 1003–1014.
160. Mao, L, Conquet, F, Wang, JQ, Augmented motor activity and reduced striatal preprodynorphin mRNA induction in response to acute amphetamine administration in metabotropic glutamate receptor 1 knockout mice. Neuroscience 106 (2001), 303–312.
161. Mao, L, Conquet, F, Wang, JQ, Impaired preprodynorphin, but not preproenkephalin, mRNA induction in the striatum of mGluR1 mutant mice in response to acute administration of the full dopamine D(1) agonist SKF-82958. Synapse 44 (2002), 86–93.
162. Mao, L, Wang, JQ, Selective activation of group I metabotropic glutamate receptors upregulates preprodynorphin, substance P, and preproenkephalin mRNA expression in rat dorsal striatum. Synapse 39 (2001), 82–94.
163. Mao, L, Wang, JQ, Activation of metabotropic glutamate receptor mediates upregulation of transcription factor mRNA expression in rat striatum induced by acute administration of amphetamine. Brain Res 924 (2002), 167–175.
164. Mao, L, Wang, JQ, Contribution of ionotropic glutamate receptors to acute amphetamine-stimulated preproenkephalin mRNA expression in the rat striatum in vivo. Neurosci Lett 346 (2003), 17–20.
165. Mao, L, Wang, JQ, Group I metabotropic glutamate receptor-mediated calcium signalling and immediate early gene expression in cultured rat striatal neurons. Eur J Neurosci 17 (2003), 741–750.
166. Mao, L, Wang, JQ, Metabotropic glutamate receptor 5-regulated Elk-1 phosphorylation and immediate early gene expression in striatal neurons. J Neurochem 85 (2003), 1006–1017.
167. Mao, L, Yang, L, Tang, Q, Samdani, S, Zhang, G, Wang, JQ, The scaffold protein Homer1b/c links metabotropic glutamate receptor 5 to extracellular signal-regulated protein kinase cascades in neurons. J Neurosci 25 (2005), 2741–2752.
168. Mao, LM, Zhang, GC, Liu, XY, Fibuch, EE, Wang, JQ, Group I metabotropic glutamate receptor-mediated gene expression in striatal neurons. Neurochem Res 33 (2008), 1920–1924.
169. Marie-Claire, C, Courtin, C, Roques, BP, Noble, F, Cytoskeletal genes regulation by chronic morphine treatment in rat striatum. Neuropsychopharmacology 29 (2004), 2208–2215.
170. Marshall, JF, Cole, BN, LaHoste, GJ, Dopamine D2 receptor control of pallidal fos expression: comparisons between intact and 6-hydroxydopamine-treated hemispheres. Brain Res 632 (1993), 308–313.
171. Marshall, JF, Henry, BL, Billings, LM, Hoover, BR, The role of the globus pallidus D2 subfamily of dopamine receptors in pallidal immediate early gene expression. Neuroscience 105 (2001), 365–378.
172. Matus-Leibovitch, N, Nevo, I, Vogel, Z, Differential distribution of synapsin IIa and IIb mRNA in various brain structures and the effect of chronic morphine administration on the regional expression of these isoforms. Brain Res Mol Brain Res 45 (1997), 301–316.
173. Mavridis, M, Besson, MJ, Dopamine-opiate interaction in the regulation of neostriatal and pallidal neuronal activity as assessed by opioid precursor peptides and glutamate decarboxylase messenger RNA expression. Neuroscience 92 (1999), 945–966.
174. McCarson, KE, Krause, JE, McLean, S, Chronic non-peptide neurokinin receptor antagonist treatment alters striatal tachykinin peptide and receptor gene expression in the rat. Neurosci Lett 251 (1998), 113–116.
175. McFarland, NR, Haber, SN, Convergent inputs from thalamic motor nuclei and frontal cortical areas to the dorsal striatum in the primate. J Neurosci 20 (2000), 3798–3813.
176. McGeorge, AJ, Faull, RL, The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 29 (1989), 503–537.
177. McGinty, JF, Shi, XD, Schwendt, M, Saylor, A, Toda, S, Regulation of psychostimulant-induced signaling and gene expression in the striatum. J Neurochem 104 (2008), 1440–1449.
178. Merchant, KM, Dorsa, DM, Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics. Proc Natl Acad Sci USA 90 (1993), 3447–3451.
179. Mijnster, MJ, Galis-de Graaf, Y, Voorn, P, Serotonergic regulation of neuropeptide and glutamic acid decarboxylase mRNA levels in the striatum and globus pallidus: studies with fluoxetine and DOI. Brain Res Mol Brain Res 54 (1998), 64–73.
180. Mijnster, MJ, Schotte, A, Docter, GJ, Voorn, P, Effects of risperidone and haloperidol on tachykinin and opioid precursor peptide mRNA levels in the caudate-putamen and nucleus accumbens of the rat. Synapse 28 (1998), 301–312.
181. Miller, JC, Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs. J Neurochem 54 (1990), 1453–1455.
182. Miwa, H, Fuwa, T, Nishi, K, Kondo, T, Subthalamo-pallido-striatal axis: a feedback system in the basal ganglia. Neuroreport 12 (2001), 3795–3798.
183. Miyachi, S, Hasegawa, YT, Gerfen, CR, Coincident stimulation of convergent cortical inputs enhances immediate early gene induction in the striatum. Neuroscience 134 (2005), 1013–1022.
184. Morelli, M, Fenu, S, Carta, A, Di Chiara, G, Effect of MK 801 on priming of D1-dependent contralateral turning and its relationship to c-fos expression in the rat caudate-putamen. Behav Brain Res 79 (1996), 93–100.
185. Morelli, M, Fenu, S, Cozzolino, A, Pinna, A, Carta, A, Di Chiara, G, Blockade of muscarinic receptors potentiates D1 dependent turning behavior and c-fos expression in 6-hydroxydopamine-lesioned rats but does not influence D2 mediated responses. Neuroscience 53 (1993), 673–678.
186. Morelli, M, Pinna, A, Fenu, S, Carta, A, Cozzolino, A, Di Chiara, G, Differential effect of MK 801 and scopolamine on c-fos expression induced by 1-dopa in the striatum of 6-hydroxydopamine lesioned rats. Synapse 18 (1994), 288–293.
187. Morelli, M, Pinna, A, Wardas, J, Di Chiara, G, Adenosine A2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats. Neuroscience 67 (1995), 49–55.
188. Mulder, AH, Wardeh, G, Hogenboom, F, Frankhuyzen, AL, Kappa- and delta-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature 308 (1984), 278–280.
189. Nakahara, T, Kuroki, T, Hashimoto, K, Hondo, H, Tsutsumi, T, Motomura, K, Ueki, H, Hirano, M, Uchimura, H, Effect of atypical antipsychotics on phencyclidine-induced expression of arc in rat brain. Neuroreport 11 (2000), 551–555.
190. Nakazato, E, Ohno, M, Watanabe, S, MK-801 reverses Fos expression induced by the full dopamine D1 receptor agonist SKF-82958 in the rat striatum. Eur J Pharmacol 342 (1998), 209–212.
191. Nisenbaum, LK, Crowley, WR, Kitai, ST, Partial striatal dopamine depletion differentially affects striatal substance P and enkephalin messenger RNA expression. Brain Res Mol Brain Res 37 (1996), 209–216.
192. Nisenbaum, LK, Kitai, ST, Crowley, WR, Gerfen, CR, Temporal dissociation between changes in striatal enkephalin and substance P messenger RNAs following striatal dopamine depletion. Neuroscience 60 (1994), 927–937.
193. Noailles, PA, Villegas, M, Ledoux, M, Lucas, LR, McEwen, BS, Angulo, JA, Acute treatment with the N-methyl-D-aspartate receptor antagonist MK-801: effect of concurrent administration of haloperidol or scopolamine on preproenkephalin mRNA levels of the striatum and nucleus accumbens of the rat brain. Neurosci Lett 202 (1996), 165–168.
194. Normand, E, Popovici, T, Onteniente, B, Fellmann, D, Piatier-Tonneau, D, Auffray, C, Bloch, B, Dopaminergic neurons of the substantia nigra modulate preproenkephalin A gene expression in rat striatal neurons. Brain Res 439 (1988), 39–46.
195. Ohno, M, Yoshida, H, Watanabe, S, NMDA receptor-mediated expression of Fos protein in the rat striatum following methamphetamine administration: relation to behavioral sensitization. Brain Res 665 (1994), 135–140.
196. Ossowska, K, Konieczny, J, Wardas, J, Gołembiowska, K, Wolfarth, S, Pilc, A, The role of striatal metabotropic glutamate receptors in Parkinson's disease. Amino Acids 23 (2002), 193–198.
197. Ossowska, K, Konieczny, J, Wardas, J, Pietraszek, M, Kuter, K, Wolfarth, S, Pilc, A, An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats. Amino Acids 32 (2007), 179–188.
198. Ossowska, K, Pietraszek, M, Wardas, J, Wolfarth, S, Potential antipsychotic and extrapyramidal effects of (R,S)-3,4-dicarboxyphenylglycine [(R,S)-3,4-DCPG], a mixed AMPA antagonist/mGluR8 agonist. Pol J Pharmacol 56 (2004), 295–304.
199. Ossowska, K, Wardas, J, Pietraszek, M, Konieczny, J, Wolfarth, S, The striopallidal pathway is involved in antiparkinsonian-like effects of the blockade of group I metabotropic glutamate receptors in rats. Neurosci Lett 342 (2003), 21–24.
200. Ozawa, T, Nakagawa, T, Shige, K, Minami, M, Satoh, M, Changes in the expression of glial glutamate transporters in the rat brain accompanied with morphine dependence and naloxone-precipitated withdrawal. Brain Res 905 (2001), 254–258.
201. Page, KJ, Everitt, BJ, Transsynaptic induction of c-fos in basal forebrain, diencephalic and midbrain neurons following AMPA-induced activation of the dorsal and ventral striatum. Exp Brain Res 93 (1993), 399–411.
202. Palmer, LC, Hess, US, Larson, J, Rogers, GA, Gall, CM, Lynch, G, Comparison of the effects of an ampakine with those of methamphetamine on aggregate neuronal activity in cortex versus striatum. Brain Res Mol Brain Res 46 (1997), 127–135.
203. Pang, Y, Kiba, H, Jayaraman, A, Acute nicotine injections induce c-fos mostly in non-dopaminergic neurons of the midbrain of the rat. Brain Res Mol Brain Res 20 (1993), 162–170.
204. Papadia, S, Hardingham, G, The dichotomy of NMDA receptor signaling. Neuroscientist 13 (2007), 572–579.
205. Parelkar, NK, Wang, JQ, Preproenkephalin mRNA expression in rat dorsal striatum induced by selective activation of metabotropic glutamate receptor subtype-5. Synapse 47 (2003), 255–261.
206. Parelkar, NK, Wang, JQ, mGluR5-dependent increases in immediate early gene expression in the rat striatum following acute administration of amphetamine. Brain Res Mol Brain Res 122 (2004), 151–157.
207. Paul, ML, Graybiel, AM, David, JC, Robertson, HA, D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J Neurosci 12 (1992), 3729–3742.
208. Pei, Q, Lewis, L, Sprakes, ME, Jones, EJ, Grahame-Smith, DG, Zetterstrom, TS, Serotonergic regulation of mRNA expression of Arc, an immediate early gene selectivity localized at neuronal dendrites. Neuropharmacology 39 (2000), 463–470.
209. Pidoplichko, VI, DeBiasi, M, Williams, JT, Dani, JA, Nicotine activates and desensitizes midbrain dopamine neurons. Nature 390 (1997), 401–404.
210. Pillot, C, Héron, A, Schwartz, JC, Arrang, JM, Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, modulates the effects of methamphetamine on neuropeptide mRNA expression in rat striatum. Eur J Neurosci 17 (2003), 307–314.
211. Pillot, C, Ortiz, J, Héron, A, Ridray, S, Schwartz, JC, Arrang, JM, Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat. J Neurosci 22 (2002), 7272–7280.
212. Pinna, A, Wardas, J, Cozzolino, A, Morelli, M, Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol. Neuropsychopharmacology 20 (1999), 44–51.
213. Pinna, A, Wardas, J, Cristalli, G, Morelli, M, Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas. Brain Res 759 (1997), 41–49.
214. Polese, D, de Serpis, AA, Ambesi-Impiombato, A, Muscettola, G, de Bartolomeis, A, Homer 1a gene expression modulation by antipsychotic drugs: involvement of the glutamate metabotropic system and effects of D-cycloserine. Neuropsychopharmacology 27 (2002), 906–913.
215. Pollack, AE, Angerer, MR, Muscarinic receptor blockade attenuates reserpine-mediated Fos induction in the rat striatopallidal pathway. Brain Res 1058 (2005), 189–192.
216. Pollack, AE, Bird, JL, Lambert, EB, Florin, ZP, Castellar, VL, Role of NMDA glutamate receptors in regulating D2 dopamine-dependent Fos induction in the rat striatopallidal pathway. Brain Res 818 (1999), 543–547.
217. Pollack, AE, Fink, JS, Adenosine antagonists potentiate D2 dopamine-dependent activation of Fos in the striatopallidal pathway. Neuroscience 68 (1995), 721–728.
218. Pollack, AE, Wooten, GF, D2 dopaminergic regulation of striatal preproenkephalin mRNA levels is mediated at least in part through cholinergic interneurons. Brain Res Mol Brain Res 13 (1992), 35–41.
219. Pompeiano, M, Palacios, JM, Mengod, G, Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res Mol Brain Res 23 (1994), 163–178.
220. Przewłocka, B, Turchan, J, Laso, W, Przewłocki, R, The effect of single and repeated morphine administration on the prodynorphin system activity in the nucleus accumbens and striatum of the rat. Neuroscience 70 (1996), 749–754.
221. Périer, C, Marin, C, Bonastre, M, Tolosa, E, Hirsch, EC, AMPA receptor antagonist LY293558 reverses preproenkephalin mRNA overexpression in the striatum of 6-OHDA-lesioned-rats treated with 1-dopa. Eur J Neurosci 16 (2002), 2236–2240.
222. Radulovic, J, Blank, T, Nijholt, I, Kammermeier, J, Spiess, J, In vivo NMDA/dopamine interaction resulting in Fos production in the limbic system and basal ganglia of the mouse brain. Brain Res Mol Brain Res 75 (2000), 271–280.
223. Rajadhyaksha, A, Barczak, A, Macías, W, Leveque, JC, Lewis, SE, Konradi, C, L-Type Ca(2+) channels are essential for glutamate-mediated CREB phosphorylation and c-fos gene expression in striatal neurons. J Neurosci 19 (1999), 6348–6359.
224. Rajadhyaksha, A, Leveque, J, Macías, W, Barczak, A, Konradi, C, Molecular components of striatal plasticity: the various routes of cyclic AMP pathways. Dev Neurosci 20 (1998), 204–215.
225. Rawls, SM, McGinty, JF, Delta opioid receptors regulate calcium-dependent, amphetamine-evoked glutamate levels in the rat striatum: an in vivo microdialysis study. Brain Res 861 (2000), 296–304.
226. Richardson, PJ, Kase, H, Jenner, PG, Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease. Trends Pharmacol Sci 18 (1997), 338–344.
227. Rivkees, SA, Price, SL, Zhou, FC, Immunohistochemical detection of A1 adenosine receptors in rat brain with emphasis on localization in the hippocampal formation, cerebral cortex, cerebellum, and basal ganglia. Brain Res 677 (1995), 193–203.
228. Robbins, MJ, Critchlow, HM, Lloyd, A, Cilia, J, Clarke, JD, Bond, B, Jones, DN, Maycox, PR, Differential expression of IEG mRNA in rat brain following acute treatment with clozapine or haloperidol: a semi-quantitative RT-PCR study. J Psychopharmacol (Oxford) 22 (2008), 536–542.
229. Robertson, GS, Vincent, SR, Fibiger, HC, D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience 49 (1992), 285–296.
230. Robertson, HA, Paul, ML, Moratalla, R, Graybiel, AM, Expression of the immediate early gene c-fos in basal ganglia: induction by dopaminergic drugs. Can J Neurol Sci 18 (1991), 380–383.
231. Robinson, TE, Castañeda, E, Whishaw, IQ, Compensatory changes in striatal dopamine neurons following recovery from injury induced by 6-OHDA or methamphetamine: a review of evidence from microdialysis studies. Can J Psychol 44 (1990), 253–275.
232. Romualdi, P, Lesa, G, Donatini, A, Ferri, S, Long-term exposure to opioid antagonists up-regulates prodynorphin gene expression in rat brain. Brain Res 672 (1995), 42–47.
233. Romualdi, P, Landuzzi, D, D'Addario, C, Candeletti, S, Modulation of proorphaninFQ/N gene expression by morphine in the rat mesocorticolimbic system. Neuroreport 13 (2002), 645–648.
234. Ruskin, DN, Marshall, JF, D1 dopamine receptors influence Fos immunoreactivity in the globus pallidus and subthalamic nucleus of intact and nigrostriatal-lesioned rats. Brain Res 703 (1995), 156–164.
235. Ruskin, DN, Marshall, JF, Differing influences of dopamine agonists and antagonists on Fos expression in identified populations of globus pallidus neurons. Neuroscience 81 (1997), 79–92.
236. Ruskin, DN, Rawji, SS, Walters, JR, Effects of full D1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo: tests for D1 receptor selectivity and comparisons to the partial agonist SKF 38393. J Pharmacol Exp Ther 286 (1998), 272–281.
237. Saklayen, SS, Mabrouk, OS, Pehek, EA, Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors. J Pharmacol Exp Ther 311 (2004), 342–348.
238. Sandstrom, MI, Sarter, M, Bruno, JP, Interactions between D1 and muscarinic receptors in the induction of striatal c-fos in rats depleted of dopamine as neonates. Brain Res Dev Brain Res 96 (1996), 148–158.
239. Schad, CA, Justice, JB Jr., Holtzman, SG, Differential effects of delta- and mu-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens. J Neurochem 67 (1996), 2292–2299.
240. Schiffmann, SN, Dassesse, D, d'Alcantara, P, Ledent, C, Swillens, S, Zoli, M, A2A receptor and striatal cellular functions: regulation of gene expression, currents, and synaptic transmission. Neurology 61 (2003), S24–S29.
241. Schiffmann, SN, Fisone, G, Moresco, R, Cunha, RA, Ferré, S, Adenosine A2A receptors and basal ganglia physiology. Prog Neurobiol 83 (2007), 277–292.
242. Schiffmann, SN, Vanderhaeghen, JJ, Caffeine regulates neurotensin and cholecystokinin messenger RNA expression in the rat striatum. Neuroscience 54 (1993), 681–689.
243. Schilström, B, Rawal, N, Mameli-Engvall, M, Nomikos, GG, Svensson, TH, Dual effects of nicotine on dopamine neurons mediated by different nicotinic receptor subtypes. Int J Neuropsychopharmacol 6 (2003), 1–11.
244. Senger, B, Brog, JS, Zahm, DS, Subsets of neurotensin-immunoreactive neurons in the rat striatal complex following antagonism of the dopamine D2 receptor: an immunohistochemical double-labeling study using antibodies against Fos. Neuroscience 57 (1993), 649–660.
245. Sgambato, V, Abo, V, Rogard, M, Besson, MJ, Deniau, JM, Effect of electrical stimulation of the cerebral cortex on the expression of the Fos protein in the basal ganglia. Neuroscience 81 (1997), 93–112.
246. Sgambato, V, Maurice, N, Besson, MJ, Thierry, AM, Deniau, JM, Effect of a functional impairment of corticostriatal transmission on cortically evoked expression of c-Fos and zif 268 in the rat basal ganglia. Neuroscience 93 (1999), 1313–1321.
247. Sharp, FR, Liu, J, Nickolenko, J, Bontempi, B, NMDA and D1 receptors mediate induction of c-fos and junB genes in striatum following morphine administration: implications for studies of memory. Behav Brain Res 66 (1995), 225–230.
248. Shoda, T, Fukuda, K, Uga, H, Mima, H, Morikawa, H, Activation of mu-opioid receptor induces expression of c-fos and junB via mitogen-activated protein kinase cascade. Anesthesiology 95 (2001), 983–989.
249. Sijbesma, H, Schipper, J, Cornelissen, JC, de Kloet, ER, Species differences in the distribution of central 5-HT1 binding sites: A comparative autoradiographic study between rat and guinea pig. Brain Res 555 (1991), 295–304.
250. Sirinathsinghji, DJ, Schuligoi, R, Heavens, RP, Dixon, A, Iversen, SD, Hill, RG, Temporal changes in the messenger RNA levels of cellular immediate early genes and neurotransmitter/receptor genes in the rat neostriatum and substantia nigra after acute treatment with eticlopride, a dopamine D2 receptor antagonist. Neuroscience 62 (1994), 407–423.
251. Sivam, SP, Breese, GR, Napier, TC, Mueller, RA, Hong, JS, Dopaminergic regulation of proenkephalin-A gene expression in the basal ganglia. NIDA Res Monogr 75 (1986), 389–392.
252. Smeal, RM, Keefe, KA, Wilcox, KS, Differences in excitatory transmission between thalamic and cortical afferents to single spiny efferent neurons of rat dorsal striatum. Eur J Neurosci 28 (2008), 2041–2052.
253. Smith, Y, Raju, DV, Pare, JF, Sidibe, M, The thalamostriatal system: a highly specific network of the basal ganglia circuitry. Trends Neurosci 27 (2004), 520–527.
254. Soghomonian, JJ, Chesselet, MF, Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat. Synapse 11 (1992), 124–133.
255. Soghomonian, JJ, Pedneault, S, Audet, G, Parent, A, Increased glutamate decarboxylase mRNA levels in the striatum and pallidum of MPTP-treated primates. J Neurosci 14 (1994), 6256–6265.
256. Spangler, R, Goddard, NL, Avena, NM, Hoebel, BG, Leibowitz, SF, Elevated D3 dopamine receptor mRNA in dopaminergic and dopaminoceptive regions of the rat brain in response to morphine. Brain Res Mol Brain Res 111 (2003), 74–83.
257. Steiner, H, Gerfen, CR, Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum. J Comp Neurol 353 (1995), 200–212.
258. Steiner, H, Gerfen, CR, Dynorphin regulates D1 dopamine receptor-mediated responses in the striatum: relative contributions of pre- and postsynaptic mechanisms in dorsal and ventral striatum demonstrated by altered immediate-early gene induction. J Comp Neurol 376 (1996), 530–541.
259. Steiner, H, Gerfen, CR, Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp Brain Res 123 (1998), 60–76.
260. Steiner, H, Gerfen, CR, Enkephalin regulates acute D2 dopamine receptor antagonist-induced immediate-early gene expression in striatal neurons. Neuroscience 88 (1999), 795–810.
261. Svenningson, P, Tzavara, ET, Qi, H, Carruthers, R, Witkin, JM, Nomikos, GG, Greengard, P, Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation. J Neurosci 27 (2007), 4201–4209.
262. Svenningsson, P, Fourreau, L, Bloch, B, Fredholm, BB, Gonon, F, Le Moine, C, Opposite tonic modulation of dopamine and adenosine on c-fos gene expression in striatopallidal neurons. Neuroscience 89 (1999), 827–837.
263. Svenningsson, P, Fredholm, BB, Caffeine mimics the effect of a dopamine D2/3 receptor agonist on the expression of immediate early genes in globus pallidus. Neuropharmacology 36 (1997), 1309–1317.
264. Svenningsson, P, Johansson, B, Fredholm, BB, Caffeine-induced expression of c-fos mRNA and NGFI-A mRNA in caudate putamen and in nucleus accumbens are differentially affected by the N-methyl-D-aspartate receptor antagonist MK-801. Brain Res Mol Brain Res 35 (1996), 183–189.
265. Svenningsson, P, Nomikos, GG, Fredholm, BB, Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration. J Neurosci 15 (1995), 7612–7624.
266. Svenningsson, P, Nomikos, GG, Ongini, E, Fredholm, BB, Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens. Neuroscience 79 (1997), 753–764.
267. Teodorov, E, Modena, CC, Sukikara, MH, Felicio, LF, Preliminary study of the effects of morphine treatment on opioid receptor gene expression in brain structures of the female rat. Neuroscience 141 (2006), 1225–1231.
268. Thomsen, MS, Mikkelsen, JD, Timmermann, DB, Peters, D, Hay-Schmidt, A, Martens, H, Hansen, HH, The selective alpha7 nicotinic acetylcholine receptor agonist A-582941 activates immediate early genes in limbic regions of the forebrain: Differential effects in the juvenile and adult rat. Neuroscience 154 (2008), 741–753.
269. Tilakaratne, N, Friedman, E, Genomic responses to 5-HT1A or 5-HT2A/2C receptor activation is differentially regulated in four regions of rat brain. Eur J Pharmacol 307 (1996), 211–217.
270. Tjon, GH, Voorn, P, Vanderschuren, LJ, de Vries, TJ, Michiels, NH, Jonker, AJ, Klop, H, Netsby, P, Mulder, AH, Schoffelmeer, AN, Delayed occurrence of enhanced striatal preprodynorphin gene expression in behaviorally sensitized rats: differential long-term effects of intermittent and chronic morphine administration. Neuroscience 76 (1997), 167–176.
271. Tomasetti, C, Dell'Aversano, C, Iasevoli, F, de Bartolomeis, A, Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action. Neuroscience 150 (2007), 144–158.
272. Tomitaka, S, Hashimoto, K, Narita, N, Minabe, Y, Tamura, A, Amantadine induces c-fos in rat striatum: reversal with dopamine D1 and NMDA receptor antagonists. Eur J Pharmacol 285 (1995), 207–211.
273. Torres, G, Rivier, C, Cocaine-induced expression of striatal c-fos in the rat is inhibited by NMDA receptor antagonists. Brain Res Bull 30 (1993), 173–176.
274. Tovar, KR, Westbrook, GL, The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J Neurosci 19 (1999), 4180–4188.
275. Turchan, J, Laso, W, Budziszewska, B, Przewłocka, B, Effects of single and repeated morphine administration on the prodynorphin, proenkephalin and dopamine D2 receptor gene expression in the mouse brain. Neuropeptides 31 (1997), 24–28.
276. Tzaferis, JA, McGinty, JF, Kappa opioid receptor stimulation decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum. Brain Res Mol Brain Res 93 (2001), 27–35.
277. Vaccarino, FM, Hayward, MD, Nestler, EJ, Duman, RS, Tallman, JF, Differential induction of immediate early genes by excitatory amino acid receptor types in primary cultures of cortical and striatal neurons. Brain Res Mol Brain Res 12 (1992), 233–241.
278. van de Witte, SV, Drukarch, B, Stoof, JC, Voorn, P, Priming with 1-DOPA differently affects dynorphin and substance P mRNA levels in the striatum of 6-hydroxydopamine-lesioned rats after challenge with dopamine D1-receptor agonist. Brain Res Mol Brain Res 61 (1998), 219–223.
279. Van De Witte, SV, Groenewegen, HJ, Voorn, P, MK-801 alters the effects of priming with 1-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons. Synapse 43 (2002), 1–11.
280. Villaró, MT, Cortés, R, Mengod, G, Serotonin 5-HT4 receptors and their mRNAs in rat and guinea pig brain: distribution and effects of neurotoxic lesions. J Comp Neurol 484 (2005), 418–439.
281. Walker, PD, Capodilupo, JG, Wolf, WA, Carlock, LR, Preprotachykinin and preproenkephalin mRNA expression within striatal subregions in response to altered serotonin transmission. Brain Res 732 (1996), 25–35.
282. Wang, JQ, Regulation of immediate early gene c-fos and zif/268 mRNA expression in rat striatum by metabotropic glutamate receptor. Brain Res Mol Brain Res 57 (1998), 46–53.
283. Wang, JQ, Daunais, JB, McGinty, JF, NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum. Synapse 18 (1994), 343–353.
284. Wang, JQ, Daunais, JB, McGinty, JF, Role of kainate/AMPA receptors in induction of striatal zif/268 and preprodynorphin mRNA by a single injection of amphetamine. Brain Res Mol Brain Res 27 (1994), 118–126.
285. Wang, JQ, McGinty, JF, Acute methamphetamine-induced zif/268, preprodynorphin, and preproenkephalin mRNA expression in rat striatum depends on activation of NMDA and kainate/AMPA receptors. Brain Res Bull 39 (1996), 349–357.
286. Wang, JQ, McGinty, JF, D1 and D2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine. Synapse 22 (1996), 114–122.
287. Wang, JQ, McGinty, JF, Intrastriatal injection of the metabotropic glutamate receptor antagonist MCPG attenuates acute amphetamine-stimulated neuropeptide mRNA expression in rat striatum. Neurosci Lett 218 (1996), 13–16.
288. Wang, JQ, McGinty, JF, Muscarinic receptors regulate striatal neuropeptide gene expression in normal and amphetamine-treated rats. Neuroscience 75 (1996), 43–56.
289. Wang, JQ, McGinty, JF, Scopolamine augments c-fos and zif/268 messenger RNA expression induced by the full D(1) dopamine receptor agonist SKF-82958 in the intact rat striatum. Neuroscience 72 (1996), 601–616.
290. Wang, JQ, McGinty, JF, The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D1/D2 interactions by muscarinic receptors. J Pharmacol Exp Ther 281 (1997), 972–982.
291. Wang, JQ, McGinty, JF, Intrastriatal injection of a muscarinic receptor agonist and antagonist regulates striatal neuropeptide mRNA expression in normal and amphetamine-treated rats. Brain Res 748 (1997), 62–70.
292. Wang, JQ, McGinty, JF, Metabotropic glutamate receptor agonist increases neuropeptide mRNA expression in rat striatum. Brain Res Mol Brain Res 54 (1998), 262–269.
293. Wang, R, Boules, M, Gollatz, E, Williams, K, Tiner, W, Richelson, E, Effects of 5 daily injections of the neurotensin-mimetic NT69L on the expression of neurotensin receptors in rat brain. Brain Res Mol Brain Res 138 (2005), 24–34.
294. Ward, RP, Dorsa, DM, Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration. Neuroscience 89 (1999), 927–938.
295. Wardas, J, Pietraszek, M, Wolfarth, S, Ossowska, K, The role of metabotropic glutamate receptors in regulation of striatal proenkephalin expression: implications for the therapy of Parkinson's disease. Neuroscience 122 (2003), 747–756.
296. Werme, M, Olson, L, Brene, S, NGFI-B and nor1 mRNAs are upregulated in brain reward pathways by drugs of abuse: different effects in Fischer and Lewis rats. Brain Res Mol Brain Res 76 (2000), 18–24.
297. Wirtshafter, D, Asin, KE, Interactive effects of stimulation of D1 and D2 dopamine receptors on fos-like immunoreactivity in the normosensitive rat striatum. Brain Res Bull 35 (1994), 85–91.
298. Wirtshafter, D, Asin, KE, Comparative effects of scopolamine and quinpirole on the striatal fos expression induced by stimulation of D(1) dopamine receptors in the rat. Brain Res 893 (2001), 202–214.
299. Yamada, M, Bolden-Waston, C, Watson, MA, Chevet, T, Coleman, NJ, Yamada, M, Richelson, E, Regulation of neurotensin receptor mRNA expression by the receptor antagoinst SR 48692 in the rat midbrain dopaminergic neurons. Brain Res Mol Brain Res 33 (1995), 343–346.
300. Yanahashi, S, Hashimoto, K, Hattori, K, Yuasa, S, Iyo, M, Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol. Brain Res 1011 (2004), 84–93.
301. 2+ -independent signaling pathway to extracellular signal-regulated protein kinase by coactivation of NMDA receptors and metabotropic glutamate receptor 5 in neurons. J Neurosci 24 (2004), 10846–10857.
302. Yano, M, Steiner, H, Methylphenidate and cocaine: the same effects on gene regulation?. Trends Pharmacol Sci 28 (2007), 588–596.
303. Yoshikawa, M, Shinomiya, T, Takayasu, N, Tsukamoto, H, Kawaguchi, M, Kobayashi, H, Oka, T, Hashimoto, A, Long-term treatment with morphine increases the D-serine content in the rat brain by regulating the mRNA and protein expressions of serine racemase and D-amino acid oxidase. J Pharmacol Sci 107 (2008), 270–276.
304. Yukhananov, RY, Handa, RJ, Effect of morphine on proenkephalin gene expression in the rat brain. Brain Res Bull 43 (1997), 349–356.
305. Zhou, Y, Bendor, J, Hofman, L, Randesi, M, Ho, A, Kreek, MJ, Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal. J Endocrinol 191 (2006), 137–145.
306. Ziolkowska, B, Gieryk, A, Bilecki, W, et al. Regulation of α-synuclein expression in limbic and motor brain regions of morphine-treated mice. J Neurosci 25 (2005), 4996–5003.
307. Ziólkowska, B, Höllt, V, The NMDA receptor antagonist MK-801 markedly reduces the induction of c-fos gene by haloperidol in the mouse striatum. Neurosci Lett 156 (1993), 39–42.
308. Ziółkowska, B, Urba ski, MJ, Wawrzcak-Bargieła, A, Bilecki, W, Przewłocki, R, Morphine activates Arc expession in the mouse striatum and in mouse neuroblastoma Neuro2A MOR1A cells expressing mu-opioid receptors. J Neurosci Res 82 (2005), 563–570.